Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

698 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.
van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, Lemmens R, Schelhaas HJ, Groen EJ, Huisman MH, van der Kooi AJ, de Visser M, Dahlberg C, Estrada K, Rivadeneira F, Hofman A, Zwarts MJ, van Doormaal PT, Rujescu D, Strengman E, Giegling I, Muglia P, Tomik B, Slowik A, Uitterlinden AG, Hendrich C, Waibel S, Meyer T, Ludolph AC, Glass JD, Purcell S, Cichon S, Nöthen MM, Wichmann HE, Schreiber S, Vermeulen SH, Kiemeney LA, Wokke JH, Cronin S, McLaughlin RL, Hardiman O, Fumoto K, Pasterkamp RJ, Meininger V, Melki J, Leigh PN, Shaw CE, Landers JE, Al-Chalabi A, Brown RH Jr, Robberecht W, Andersen PM, Ophoff RA, van den Berg LH. van Es MA, et al. Among authors: van der kooi aj, van den berg lh, van doormaal pt, van vught pw. Nat Genet. 2009 Oct;41(10):1083-7. doi: 10.1038/ng.442. Epub 2009 Sep 6. Nat Genet. 2009. PMID: 19734901
A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JH, Franssen H, van den Berg LH. Groeneveld GJ, et al. Among authors: van der tweel i, van den berg lh. Ann Neurol. 2003 Apr;53(4):437-45. doi: 10.1002/ana.10554. Ann Neurol. 2003. PMID: 12666111 Clinical Trial.
Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
van Sorge NM, van den Berg LH, Geleijns K, van Strijp JA, Jacobs BC, van Doorn PA, Wokke JH, van de Winkel JG, Leusen JH, van der Pol WL. van Sorge NM, et al. Among authors: van der pol wl, van strijp ja, van den berg lh, van doorn pa, van de winkel jg. Ann Neurol. 2003 May;53(5):570-9. doi: 10.1002/ana.10503. Ann Neurol. 2003. PMID: 12730990
Rehabilitation care for patients with ALS in The Netherlands.
van den Berg JP, Kalmijn S, Lindeman E, Wokke JH, van den Berg LH. van den Berg JP, et al. Among authors: van den berg lh. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):186-90. doi: 10.1080/aml.4.3.186.190. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 13129805
Physician-assisted death: dying with dignity?
Reagan P, Hurst R, Cook L, Zylicz Z, Otlowski M, Veldink JH, van den Berg LH, Wokke JH. Reagan P, et al. Among authors: van den berg lh. Lancet Neurol. 2003 Oct;2(10):637-43. doi: 10.1016/s1474-4422(03)00536-2. Lancet Neurol. 2003. PMID: 14505588 No abstract available.
Sequential designs for clinical trials in amyotrophic lateral sclerosis.
Groeneveld GJ, van der Tweel I, Wokke JH, van den Berg LH. Groeneveld GJ, et al. Among authors: van der tweel i, van den berg lh. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):202-7. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15799547
CGP 3466B has no effect on disease course of (G93A) mSOD1 transgenic mice.
Groeneveld GJ, van Muiswinkel FL, de Leeuw van Weenen J, Blauw H, Veldink JH, Wokke JH, van den Berg LH, Bär PR. Groeneveld GJ, et al. Among authors: van muiswinkel fl, van den berg lh. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Dec;5(4):220-5. doi: 10.1080/14660820410019530. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15799550
Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms.
van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, van de Winkel JG, van den Berg LH. van Sorge NM, et al. Among authors: van der pol wl, van den berg lh, van doorn pa, van schaik in, van de winkel jg. J Neuroimmunol. 2005 May;162(1-2):157-64. doi: 10.1016/j.jneuroim.2005.01.016. J Neuroimmunol. 2005. PMID: 15833371
698 results